Overview

Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open-label, non-randomized, dose-finding, study of Vitamin E δ-Tocotrienol in subjects with resectable pancreatic tumors.
Phase:
Phase 1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
BioGene Life Science
National Cancer Institute (NCI)
Treatments:
alpha-Tocopherol
Tocopherols
Tocotrienols
Vitamin E
Vitamins